Cost-effectiveness of digital breast tomosynthesis versus digital mammography for breast cancer screening: a systematic literature review
References
- Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanisławek A. Breast cancer—epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—an updated review. Cancers (Basel). 2021; 13:4287. doi: 10.3390/cancers13174287
- Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 2025; 31:1154–62.
- Zhang S, Jin Z, Bao L, Shu P. The global burden of breast cancer in women from 1990 to 2030: assessment and projection based on the global burden of disease study 2019. Front Oncol. 2024; 14:1364397. doi: 10.3389/fonc.2024.1364397
- Chotai N, Renganathan R, Uematsu T, Wang J, Zhu Q, Rahmat K, et al. Breast cancer screening in Asian countries: epidemiology, screening practices, outcomes, challenges, and future directions. Korean J Radiol. 2025; 26:743. doi: 10.3348/kjr.2025.0338
- Ren W, Chen M, Qiao Y, Zhao F. Global guidelines for breast cancer screening: a systematic review. The Breast. 2022; 64:85–9.
- Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74:229–63.
- The Independent UK, Panel on Breast Cancer Screening, Marmot MG, Altman DG, Cameron DA, Dewar JA, et al. The benefits and harms of breast cancer screening: an independent review: a report jointly commissioned by cancer research UK and the department of health (England) October 2012. Br J Cancer. 2013; 108:2205–40.
- Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013; 2013:CD001877. doi: 10.1002/14651858.CD001877.pub5
- American Cancer Society. Survival rates for breast cancer [Internet]. Atlanta (GA): American Cancer Society; 2025 [cited 2025 Aug 14]. Available from:
https://www.cancer.org/cancer/types/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html - US Preventive Services Task Force, Nicholson WK, Silverstein M, Wong JB, Barry MJ, Chelmow D, et al. Screening for breast cancer: US preventive services task force recommendation statement. JAMA. 2024; 331:1918. doi: 10.1001/jama.2024.5534
- De Munck L, De Bock GH, Otter R, Reiding D, Broeders MJ, Willemse PH, et al. Digital vs screen-film mammography in population-based breast cancer screening: performance indicators and tumour characteristics of screen-detected and interval cancers. Br J Cancer. 2016; 115:517–24.
- Gilbert FJ, Tucker L, Young KC. Digital breast tomosynthesis (DBT): a review of the evidence for use as a screening tool. Clin Radiol. 2016; 71:141–50.
- Chung W-S, Wan TTH, Shiu YT, Shi H-Y. Cost-effectiveness analysis of digital breast tomosynthesis and mammography in breast cancer screening: a Markov modeling study. J Epidemiol Glob Health. 2024; 14:933–46.
- Lee CI, Lehman CD. Digital breast tomosynthesis and the challenges of implementing an emerging breast cancer screening technology into clinical practice. J Am Coll Radiol. 2013; 10:913–7.
- Marinovich ML, Hunter KE, Macaskill P, Houssami N. Breast cancer screening using tomosynthesis or mammography: a meta-analysis of cancer detection and recall. J Natl Cancer Inst. 2018; 110:942–9.
- Houssami N, Zackrisson S, Blazek K, Hunter K, Bernardi D, Lång K, et al. Meta-analysis of prospective studies evaluating breast cancer detection and interval cancer rates for digital breast tomosynthesis versus mammography population screening. Eur J Cancer. 2021; 148:14–23.
- Ho T-QH, Bissell MCS, Kerlikowske K, Hubbard RA, Sprague BL, Lee CI, et al. Cumulative probability of false-positive results after 10 years of screening with digital breast tomosynthesis vs digital mammography. JAMA Netw Open. 2022; 5:e222440. doi: 10.1001/jamanetworkopen.2022.2440
- Hodgson R, Heywang-Köbrunner SH, Harvey SC, Edwards M, Shaikh J, Arber M, et al. Systematic review of 3D mammography for breast cancer screening. The Breast. 2016; 27:52–61.
- Zackrisson S, Lång K, Rosso A, Johnson K, Dustler M, Förnvik D, et al. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study. Lancet Oncol. 2018; 19:1493–503.
- Phi X-A, Tagliafico A, Houssami N, Greuter MJW, De Bock GH. Digital breast tomosynthesis for breast cancer screening and diagnosis in women with dense breasts – a systematic review and meta-analysis. BMC Cancer. 2018; 18:380. doi: 10.1186/s12885-018-4263-3
- Rashidian A, Barfar E, Hosseini H, Nosratnejad S, Barooti E. Cost effectiveness of breast cancer screening using mammography; a systematic review. Iran J Public Health. 2013; 42:347–57.
- Jayasekera J, Mandelblatt JS. Systematic review of the cost effectiveness of breast cancer prevention, screening, and treatment interventions. J Clin Oncol. 2020; 38:332–50.
- Couto HL, Gargano LP, de Oliveira VM, Coelho BA, Pessoa EC, Hassan AT, et al. Cost-effectiveness analysis of digital breast tomosynthesis added to synthetic mammography in breast cancer screening in Brazil. PharmacoEconomics - Open. 2024; 8:403–16.
- Lee CI, Cevik M, Alagoz O, Sprague BL, Tosteson AN, Miglioretti DL, et al. Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts. Radiology. 2015; 274:772–80.
- Kalra VB, Wu X, Haas BM, Forman HP, Philpotts LE. Cost-effectiveness of tomosynthesis in annual screening mammography. Am J Roentgenol. 2016; 207:1152–5.
- Icanervilia AV, van der Schans J, Cao Q, de Carvalho AC, Cordova-Pozo K, At Thobari J, et al. Economic evaluations of mammography to screen for breast cancer in low- and middle-income countries: a systematic review. J Glob Health. 2022; 12:04048. doi: 10.7189/jogh.12.04048
- Lowry KP, Coley RY, Miglioretti DL, Kerlikowske K, Henderson LM, Onega T, et al. Screening performance of digital breast tomosynthesis vs digital mammography in community practice by patient age, screening round, and breast density. JAMA Netw Open. 2020; 3:e2011792. doi: 10.1001/jamanetworkopen.2020.11792
- Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. Cochrane handbook for systematic reviews of interventions. version 6.5 (updated August 2024). Cochrane; 2024.
www.training.cochrane.org/handbook - Centre for Reviews and Dissemination. Systematic reviews: CRD’s guidance for undertaking reviews in health care [Internet]. York (UK): University of York; 2009 [cited 2025 Aug 14]. Available from:
https://www.york.ac.uk/crd/guidance/ - Bennett A, Shaver N, Vyas N, Almoli F, Pap R, Douglas A, et al. Screening for breast cancer: a systematic review update to inform the Canadian Task Force on Preventive Health Care guideline. Systematic Reviews. 2024; 13:304. doi: 10.1186/s13643-024-02700-3
- Henderson JT, Webber EM, Weyrich MS, Miller M, Melnikow J. Screening for breast cancer: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2024; 331:1931. doi: 10.1001/jama.2023.25844
- Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ. 1996; 313:275–83.
- Hunter SA, Morris C, Nelson K, Snyder BJ, Poulton TB. Digital breast tomosynthesis: cost-effectiveness of using private and medicare insurance in community-based health care facilities. Am J Roentgenol. 2017; 208:1171–5.
- Bonafede MM, Kalra VB, Miller JD, Fajardo LL. Value analysis of digital breast tomosynthesis for breast cancer screening in a commercially-insured US population. Clinicoecon Outcomes Res. 2015; 7:53–63.
- Dhurandhar V, Bhola N, Chan M, Choi S, Chung TY, Giuffre B, et al. Feasibility study comparing synthesized mammography with digital breast tomosynthesis and digital mammography for simulated first round screening in a single BreastScreen NSW centre. J Med Imaging Radiat Oncol. 2024; 68:401–11.
- Djuric O, Deandrea S, Mantellini P, Sardanelli F, Venturelli F, Montemezzi S, et al. Budget impact analysis of introducing digital breast tomosynthesis in breast cancer screening in Italy. Radiol Med. 2024; 129:1288–302.
- Miller JD, Bonafede MM, Herschorn SD, Pohlman SK, Troeger KA, Fajardo LL. Value analysis of digital breast tomosynthesis for breast cancer screening in a US Medicaid population. J Am Coll Radiol. 2017; 14:467–74.e5.
- Donin G, Včelišová T. EE112 cost-effectiveness of digital breast tomosynthesis in mammography screening in women with high breast density from a Czech perspective. Value in Health. 2022; 25:S75. doi: 10.1016/j.jval.2022.09.364
- Liao G, Glick H, Synnestvedt M, Schnall M, Conant E. Abstract PD7-05: comparative costs of breast cancer screening with digital breast tomosynthesis versus digital mammography: a health system perspective. Cancer Res. 2018; 78(Suppl 4):D7–05.
- Semprini J, Vaughan-Sarrazin M. Breast density notification with adjunctive digital breast tomosynthesis (DBT): a cost-effectiveness analysis. J Clin Oncol. 2020; 38(Suppl 15):7072. doi: 10.1200/JCO.2020.38.15_suppl.7072
- Wang J, Daszczuk AM, Greuter MJ, Feenstra TL, Pijnappel RM, Vermeulen KM, et al. Early health technology assessment of digital breast tomosynthesis in national breast cancer screening. Eur J Cancer. 2018; 92:S89–90.
- Ontario Health (Quality). Supplemental screening as an adjunct to mammography for breast cancer screening in people with dense breasts: a health technology assessment. Ont Health Technol Assess Ser. 2023; 23:1–293.
- Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. doi: 10.1136/bmj.n71
- Lowry KP, Trentham-Dietz A, Schechter CB, Alagoz O, Barlow WE, Burnside ES, et al. Long-term outcomes and cost-effectiveness of breast cancer screening with digital breast tomosynthesis in the United States. J Natl Cancer Inst. 2020; 112:582–9.
- Sankatsing VDV, Juraniec K, Grimm SE, Joore MA, Pijnappel RM, De Koning HJ, et al. Cost-effectiveness of digital breast tomosynthesis in population-based breast cancer screening: a probabilistic sensitivity analysis. Radiology. 2020; 297:40–8.
- Wang J, Phi X-A, Greuter MJW, Daszczuk AM, Feenstra TL, Pijnappel RM, et al. The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program. Eur Radiol. 2020; 30:5437–45.
- Cressman S, Mar C, Sam J, Kan L, Lohrisch C, Spinelli JJ. The cost-effectiveness of adding tomosynthesis to mammography-based breast cancer screening: an economic analysis. CMAJ Open. 2021; 9:E443–50.
- Moger TA, Holen Å, Hanestad B, Hofvind S. Costs and effects of implementing digital tomosynthesis in a population-based breast cancer screening program: predictions using results from the To-Be trial in Norway. PharmacoEcon Open. 2022; 6:495–507.
- Fridhammar A, Johnson K, Rosso A, Andersson E, Andersson I, Lång K, et al. Cost effectiveness of digital breast tomosynthesis for breast cancer screening in a Swedish setting. Eur J Radiol. 2025; 187:112088. doi: 10.1016/j.ejrad.2025.112088
- Hofvind S, Holen ÅS, Aase HS, Houssami N, Sebuødegård S, Moger TA, et al. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial. Lancet Oncol. 2019; 20:795–805.
- Aase HS, Holen ÅS, Pedersen K, Houssami N, Haldorsen IS, Sebuødegård S, et al. A randomized controlled trial of digital breast tomosynthesis versus digital mammography in population-based screening in Bergen: interim analysis of performance indicators from the To-Be trial. Eur Radiol. 2019; 29:1175–86.
- Pan H-B, Wong K-F, Yao A, Hsu G-C, Chou CP, Liang H-L, et al. Breast cancer screening with digital breast tomosynthesis - 4 year experience and comparison with national data. Journal Chin Med Assoc. 2018; 81:70–80.
- Friedewald SM, Rafferty EA, Rose SL, Durand MA, Plecha DM, Greenberg JS, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014; 311:2499. doi: 10.1001/jama.2014.6095
- Skaane P, Bandos AI, Gullien R, Eben EB, Ekseth U, Haakenaasen U, et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology. 2013; 267:47–56.
- Conant EF, Beaber EF, Sprague BL, Herschorn SD, Weaver DL, Onega T, et al. Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR consortium. Breast Cancer Res Treat. 2016; 156:109–16.
- Conant EF, Barlow WE, Herschorn SD, Weaver DL, Beaber EF, Tosteson ANA, et al. Association of digital breast tomosynthesis vs digital mammography with cancer detection and recall rates by age and breast density. JAMA Oncol. 2019; 5:635. doi: 10.1001/jamaoncol.2018.7078
- Houssami N, Bernardi D, Caumo F, Brunelli S, Fantò C, Valentini M, et al. Interval breast cancers in the STORM (screening with tomosynthesis or standard mammography) population-based trial. Breast. 2018; 38:150–3.
- Skaane P, Sebuødegård S, Bandos AI, Gur D, Østerås BH, Gullien R, et al. Performance of breast cancer screening using digital breast tomosynthesis: results from the prospective population-based Oslo Tomosynthesis Screening Trial. Breast Cancer Res Treat. 2018; 169:489–96.
- Destounis S, Johnston L, Highnam R, Arieno A, Morgan R, Chan A. Using volumetric breast density to quantify the potential masking risk of mammographic density. AJR Am J Roentgenol. 2017; 208:222–7.
- Skaane P, Hofvind S, Skjennald A. Randomized trial of screen-film versus full-field digital mammography with soft-copy reading in population-based screening program: follow-up and final results of Oslo II study. Radiology. 2007; 244:708–17.
- Papanicolas I, Woskie LR, Jha AK. Health care spending in the United States and other high-income countries. JAMA. 2018; 319:1024. doi: 10.1001/jama.2018.1150
- Miglioretti DL, Zhu W, Kerlikowske K, Sprague BL, Onega T, Buist DS, et al. Breast tumor prognostic characteristics and biennial vs annual mammography, age, and menopausal status. JAMA Oncol. 2015; 1:1069. doi: 10.1001/jamaoncol.2015.3084
- García-Albéniz X, Hernán MA, Logan RW, Price M, Armstrong K, Hsu J. Continuation of annual screening mammography and breast cancer mortality in women older than 70 years. Ann Intern Med. 2020; 172:381–9.
- Duffy SW, Vulkan D, Cuckle H, Parmar D, Sheikh S, Smith RA, et al. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial. Lancet Oncol. 2020; 21:1165–72.
- Wilkinson AN, Mainprize JG, Yaffe MJ, Robinson J, Cordeiro E, Look Hong NJ, et al. Cost-effectiveness of breast cancer screening using digital mammography in Canada. JAMA Netw Open. 2025; 8:e2452821. doi: 10.1001/jamanetworkopen.2024.52821
- Sprague BL, Gangnon RE, Burt V, Trentham-Dietz A, Hampton JM, Wellman RD, et al. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst. 2014; 106:dju255. doi: 10.1093/jnci/dju255
- Hofvind S, Moshina N, Holen ÅS, Danielsen AS, Lee CI, Houssami N, et al. Interval and subsequent round breast cancer in a randomized controlled trial comparing digital breast tomosynthesis and digital mammography screening. Radiology. 2021; 300:66–76.
- Briggs AH. Claxton K, Sculpher M, editors. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2011.
- Drummond M. Methods for the economic evaluation of health care programmes. 4th ed. Oxford: Oxford University Press; 2015.
- Karnon J. Alternative decision modelling techniques for the evaluation of health care technologies: markov processes versus discrete event simulation. Health Econ. 2003; 12:837–48.
- Kim DD, Wilkinson CL, Pope EF, Chambers JD, Cohen JT, Neumann PJ. The influence of time horizon on results of cost-effectiveness analyses. Expert Rev Pharmacoecon Outcomes Res. 2017; 17:615–23.
- Caro JJ, Briggs AH, Siebert U, Kuntz KM. Modeling good research practices—overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1. Value Health. 2012; 15:796–803.
Language: English
Page range: 208 - 229
Published on: Aug 31, 2026
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2026 Supakorn Chansaengpetch, Lisa Stirk, Nigel Armstrong, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution 4.0 License.